IFNG and COVID-19: For example, the magnitude of the S976–984-specific IFN-γ-producing CD8+ T-cell response followed a clear downside trend, as the disease severity increased in severely ill symptomatic COVID-19 patients and patients with fatal outcomes (i.e., severity 3–5) (Figures 2A, C and Supplementary Figure 5).